Similar Search Results

The signaling effects of incremental information : evidence from stacked US Food and Drug Administration designations

Miller, Kathleen L.; Nardinelli, Clark; Pink, George H.; … - In: The quarterly review of economics and finance : journal … 67 (2018), pp. 219-226

Persistent link: https://www.econbiz.de/10012034461

How the reformulation of oxycontin ignited the heroin epidemic

Evans, William N.; Lieber, Ethan M. J.; Power, Patrick - In: The review of economics and statistics 101 (2019) 1, pp. 1-15

Persistent link: https://www.econbiz.de/10012039246

How the reformulation of OxyContin ignited the heroin epidemic

Evans, William N.; Lieber, Ethan; Power, Patrick - 2018

Persistent link: https://www.econbiz.de/10011845629

Drug shortages, pricing, and regulatory activity

Stomberg, Christopher - In: Measuring and modeling health care costs, (pp. 323-348). 2018

Persistent link: https://www.econbiz.de/10011812711

Medical marijuana laws and mental health in the United States

Kalbfuß, Jörg; Odermatt, Reto; Stutzer, Alois - 2018

Persistent link: https://www.econbiz.de/10011883214

How do opioid prescribing restrictions affect pharmaceutical promotion? : lessons from the Mandatory Access Prescription Drug Monitoring Programs

Nguyen, Thuy D.; Bradford, W. David; Simon, Kosali … - 2019

Persistent link: https://www.econbiz.de/10012129222

Orphan Drug designations as valuable intangible assets for IPO investors in pharma-biotech companies

Gorry, Philippe; Useche, Diego - 2017

Persistent link: https://www.econbiz.de/10011772985

Sharing RD risk in healthcare via FDA hedges

Jørring, Adam; Lo, Andrew W.; Philipson, Tomas J.; … - 2017 - This draft: 28 March 2017

The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...

Persistent link: https://www.econbiz.de/10011749446

Sex, drugs, and baby booms : can behavior overcome biology?

Baggio, Michele; Chong, Alberto; Simon, David - 2018

Persistent link: https://www.econbiz.de/10011953626

Sharing R&D risk in healthcare via FDA hedges

Jørring, Adam; Lo, Andrew W.; Philipson, Tomas J.; … - 2017

Persistent link: https://www.econbiz.de/10011656884